Answers are grounded in this paper and cite their sources.
To The Editor: early 2020, multisystemic inflammatory syndrome in children (MIS-C) was recognized as an emerging life-threatening disease occurring 2 to 6 weeks after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with symptoms resembling those of Kawasaki’s disease or toxic shock syndrome.1 Unlike typical Kawasaki’s disease, MIS-C has been frequently associated with gastrointestinal symptoms and circulatory failure necessitating treatment with vasoactive drugs.
No takes yet. Share an insight, caveat, or question.
Benezech et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: